or Try an Advanced Search...

    ETF Components for XBI - SPDR S&P Biotech ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ALPN A 0.00 1.89
    RVMD A 2.58 1.26
    BMRN F -1.62 1.22
    EXEL D -0.99 1.22
    EXAS F 2.53 1.21
    MRNA B -0.47 1.21
    NTRA A 3.48 1.18
    CRNX A 0.90 1.17
    CERE A -0.09 1.16
    CYTK D 1.45 1.16
    BPMC A 0.18 1.15
    AMGN A 11.82 1.14
    NBIX A 0.63 1.14
    SRPT B 2.32 1.14
    UTHR A 1.65 1.12
    IONS F -2.60 1.11
    VRTX D 0.23 1.11
    ALNY D 1.34 1.10
    RYTM C 6.78 1.09
    DYN D 0.31 1.08
    ABBV D 1.85 1.08
    GERN B -0.51 1.08
    REGN B 2.07 1.07
    HALO D 0.23 1.07
    KRYS D 0.54 1.06
    INSM D -0.43 1.06
    BIIB D 1.87 1.04
    VKTX C 1.60 1.04
    IMVT F 0.28 1.04
    IRWD F -2.17 1.03
    GILD F -0.84 1.02
    DVAX D 0.17 1.00
    IDYA D 1.66 1.00
    RARE D -1.04 1.00
    INCY D 1.26 0.99
    BBIO F 0.32 0.99
    VCEL C -0.10 0.99
    FOLD F -0.29 0.98
    ALKS F 0.80 0.97
    SNDX D 0.87 0.97
    RCKT D 3.07 0.97
    SWTX D 4.06 0.97
    PCVX D 2.18 0.95
    TGTX C -1.40 0.95
    TWST B 28.74 0.94
    PTCT B -1.81 0.93
    KYMR D 3.03 0.93
    APLS F -0.06 0.93
    MDGL D 6.38 0.92
    CPRX D -2.00 0.92
    NUVL D -2.95 0.91
    ARQT D -6.98 0.90
    CLDX C 4.16 0.89
    AGIO A -0.12 0.88
    INBX D 0.41 0.87
    VERA C -0.14 0.87
    NVAX D 4.67 0.87
    DNLI F 1.96 0.85
    ARDX C 28.42 0.85
    IOVA D 5.82 0.85
    ACLX D -1.13 0.84
    KROS D 6.08 0.84
    BCRX F -0.67 0.83
    CRSP F 1.49 0.81
    NTLA F 1.42 0.81
    ACAD F -0.18 0.81
    RXRX F 0.57 0.81
    ARWR F 1.28 0.80
    MIRM D 0.94 0.80
    PRTA F 4.04 0.78
    ALT D 1.53 0.78
    VCYT D 0.79 0.77
    PTGX D 2.15 0.77
    MORF F 4.14 0.76
    AKRO F -0.25 0.74
    KURA D 0.19 0.73
    SAGE F 6.37 0.69
    MGNX D 2.96 0.69
    BEAM F 1.80 0.69
    VRDN F 5.62 0.67
    CCCC D 4.82 0.67
    RCUS F 1.29 0.66
    BMEA F 3.52 0.64
    RNA A 3.40 0.63
    SRRK C 1.66 0.61
    COGT C 3.29 0.58
    MYGN D 1.30 0.58
    CABA F -1.67 0.57
    XNCR C 2.03 0.55
    ADMA A 1.04 0.55
    EDIT F 0.89 0.54
    ARCT F 2.83 0.53
    SANA C 6.75 0.53
    REPL F 5.95 0.51
    ETNB F 4.06 0.50
    FDMT D 0.00 0.47
    CDMO B 0.61 0.45
    ZNTL F 5.40 0.44
    VIR C 13.18 0.44
    TVTX F 1.62 0.41
    DCPH A 0.00 0.40
    FATE D -0.98 0.39
    MNKD D 0.23 0.38
    DAWN A -2.28 0.37
    RLAY F -0.56 0.37
    OLMA F 5.96 0.37
    RGNX F 1.14 0.36
    NRIX D 0.39 0.36
    CDNA C 4.85 0.36
    IRON F 2.72 0.35
    VERV F 4.23 0.35
    KNSA C 3.61 0.31
    ALLO F 3.37 0.30
    AVXL F 2.39 0.29
    SMMT C 8.13 0.29
    CRBU F 3.57 0.26
    CGEM A 2.79 0.23
    MDXG D -1.73 0.23
    ANAB B 0.91 0.22
    ALEC F 0.94 0.18
    MRSN D 2.98 0.13
    SPRY C 3.07 0.12
    ORIC D 2.00 0.11
    VYGR D 3.28 0.11
    RCEL F 0.34 0.06

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Medicine Biology Immune System Clinical Development Immunology Solid Tumors Disease Antibodies Organ Systems Monoclonal Antibodies Treatment Of Cancer Autoimmune Disease Monoclonal Antibody Enzymes Genetics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices

    Recent News for SPDR S&P Biotech ETF & its Holdings

    Date Stock Title
    May 4 MRNA Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
    May 3 VRTX Insider Sale at Vertex Pharmaceuticals Inc (VRTX): Director Sangeeta Bhatia Sells Shares
    May 3 XNCR Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares
    May 3 AMGN Why Amgen Stock Zoomed Nearly 12% Higher Today
    May 3 NTLA Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
    May 3 CRSP CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know
    May 3 RXRX Recursion Pharmaceuticals (RXRX) Increases Yet Falls Behind Market: What Investors Need to Know
    May 3 AMGN Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
    May 3 FATE Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
    May 3 CDNA CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    May 3 RARE Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
    May 3 AMGN Analyst unveils Amgen stock price target after weight-loss drug data
    May 3 UTHR 30 Most Profitable Companies with Highest Margins in the World
    May 3 RNA BofA starts Avidity at buy, cites upcoming clinical data
    May 3 GILD Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
    May 3 KROS Keros Therapeutics files automatic mixed shelf
    May 3 AMGN Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
    May 3 TWST Twist Bioscience: NGS Is Taking Off
    May 3 TWST Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised
    May 3 NBIX Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
    Index Fund Stock Market Index Biotechnology S&P Total Market Index ( Biotechnology Segment
    Back to the Main XBI Page...